Renal amino acid, fat and glucose metabolism in type 1 diabetic and non-diabetic humans: Effects of acute insulin withdrawal

Diabetologia

Volumn 49, Issue 8, 2006, Pages 1901-1908

  Moller, N ^a,b   Jensen, M D ^a   Rizza, R A ^a   Andrews, J C ^a   Nair, K S ^a  

^a Mayo Clinic   (United States)

^b AARHUS UNIVERSITY HOSPITAL   (Denmark)

Author keywords

Arteriovenous kidney and leg technique; Glucose; Indirect calorimetry; Leucine; Palmitate; Tracers

Indexed keywords

AMINO ACID; C PEPTIDE; FAT; GLUCOSE; INSULIN; LEUCINE; PALMITIC ACID; PHENYLALANINE; TYROSINE;

ADULT; AMINO ACID METABOLISM; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG EFFECT; FEMALE; FEMORAL ARTERY; FEMORAL VEIN; GLUCONEOGENESIS; GLUCOSE METABOLISM; HUMAN; INSULIN DEPENDENT DIABETES MELLITUS; KIDNEY; KIDNEY VEIN; LIPID METABOLISM; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM; STATISTICAL SIGNIFICANCE; TRANSAMINATION; TREATMENT WITHDRAWAL;

AMINO ACIDS; BLOOD FLOW VELOCITY; DIABETES MELLITUS, TYPE 1; GLUCOSE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; KIDNEY; LEUCINE; PALMITIC ACID; PHENYLALANINE; REFERENCE VALUES; RENAL CIRCULATION; SUBSTANCE WITHDRAWAL SYNDROME; TYROSINE;

EID: 33745771552     PISSN: 0012186X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00125-006-0287-3     Document Type: Article

References (30)

1. Miles JM, Rizza RA, Haymond MW, Gerich J (1980) Effects of acute insulin deficiency on glucose and ketone body turnover in man. Evidence for the primacy of overproduction of glucose and ketone bodies in the genesis of diabetic ketoacidosis. Diabetes 29:926-930
2. Nair KS, Garrow JS, Ford C, Mahler RF, Halliday D (1983) Effect of poor diabetic control and obesity on whole body protein metabolism in man. Diabetologia 25:400-403
3. Nair KS, Ford GC, Ekberg K, Fernqvist-Forbes E, Wahren J (1995) Protein dynamics in whole body and in splanchnic and leg tissues in type I diabetic patients. J Clin Invest 95:2926-2937
4. Stumvoll M, Meyer C, Mitrakou A, Nadkarni V, Gerich JE (1997) Renal glucose production and utilization: new aspects in humans. Diabetologia 40:749-757
5. Cersosimo E, Judd RL, Miles JM (1994) Insulin regulation of renal glucose metabolism in conscious dogs. J Clin Invest 93:2584-2589
6. Stumvoll M, Chintalapudi U, Perriello G, Welle SL, Gutierrez O, Gerich JE (1995) Uptake and release of glucose by the human kidney. Postabsorptive rates and responses to epinephrine. J Clin Invest 96:2528-2533
7. Stumvoll M, Meyer C, Perriello G, Kreider M, Welle S, Gerich J (1998) Human kidney and liver gluconeogenesis: evidence for organ substrate selectivity. Am J Physiol 274:E817-E826
8. Stumvoll M, Meyer C, Kreider M, Perriello G, Gerich J (1998) Effects of glucagon on renal and hepatic glutamine gluconeo-genesis in normal postabsorptive humans. Metabolism 47:1227-1232
9. Meyer C, Stumvoll M, Nadkarni V, Dostou J, Mitrakou A, Gerich J (1998) Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. J Clin Invest 102:619-624
10. Cersosimo E, Garlick P, Ferretti J (1999) Insulin regulation of renal glucose metabolism in humans. Am J Physiol 276:E78-E84
11. Cersosimo E, Garlick P, Ferretti J (1999) Renal glucose production during insulin-induced hypoglycemia in humans. Diabetes 48:261-266
12. Ekberg K, Landau BR, Wajngot A et al (1999) Contributions by kidney and liver to glucose production in the postabsorptive state and after 60 h of fasting. Diabetes 48:292-298
13. Tessari P, Garibotto G, Inchiostro S et al (1996) Kidney, splanchnic, and leg protein turnover in humans: insight from phenylalanine kinetics. J Clin Invest 98:1481-1492
14. Moller N, Meek S, Bigelow M, Andrews J, Nair KS (2000) The kidney is an important site for in vivo phenylalanine-to-tyrosine conversion in adult humans: a metabolic role of the kidney. Proc Natl Acad Sci USA 97:1242-1246
15. Nieth H, Schollmeyer P (1966) Substrate utilization of the human kidney. Nature 209:1244-1245
16. Wahren J, Felig P (1975) Renal substrate exchange in human diabetes mellitus. Diabetes 24:730-734
17. Brundin T, Wahren J (1994) Renal oxygen consumption, thermogenesis, and amino acid utilization during i.v. infusion of amino acids in man. Am J Physiol 267:E648-E655
18. Charlton MR, Adey DB, Nair KS (1996) Evidence for a catabolic role of glucagon during an amino acid load. J Clin Invest 98:90-99
19. 2]-D-glucose-enriched plasma samples by gas chromatography-mass spectrometry. J Chromatogr Appl 572:302-306
20. Jensen MD, Rogers PJ, Ellman MG, Miles JM (1988) Choice of infusion-sampling mode for tracer studies of free fatty acid metabolism. Am J Physiol 254:E562-E656
21. 5] phenylalanine model. Am J Physiol 256:E631-E639
22. 15N)leucine and forearm model. Eur J Clin Invest 15:345-353
23. Wolfe RR (1992) Radioactive and stable isotopes tracers in biomedicine. In: Principles and Practice of Kinetic Analysis. Wiley-Liss, New York p. 186
24. Jensen MD, Cryer PE, Johnson CM, Murray MJ (1996) Effects of epinephrine on regional free fatty acid and energy metabolism in men and women. Am J Physiol 270:E259-E264
25. Geyelin HR, Harrop G, Murray MF, Corwin E (1922) The use of insulin in juvenile diabetes. J Metab Res 11:767-791
26. Atchley DW, Loeb RF, Richards DW Jr, Benedict EIM, Driscoll ME (1933) On diabetic acidosis - a detailed study of electrolyte balances following the withdrawal and reestablishment of insulin therapy. J Clin Invest 12:297-326
27. Walsh CH, Soler NG, James H et al (1976) Studies in whole body potassium and whole body nitrogen in newly diagnosed diabetics. Q J Med 45:295-301
28. Moller N, Rizza RA, Ford GC, Nair KS (2001) Assessment of postabsorptive renal glucose metabolism in humans with multiple glucose tracers. Diabetes 50:747-751
29. Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes. Diabetes Care 24:1522-1527
30. Jensen MD, Ekberg K, Landau BR (2001) Lipid metabolism during fasting. Am J Physiol - Endocrinol Metab 281:E789-E793